BIG Investment Group LLC 1 hr · Edited · Nanotech

New Post Public Reply Private Reply Replies (0) Message Board
lajet

Quote:
BIG Investment Group LLC
1 hr · Edited ·
Nanotech Entertainment held their first quarterly conference call today, Thursday March 12th, 2015.
There was a ton of great news shared just delivered in an underwhelming manner IMO. I will attempt to highlight the key points and expand on them based on my understanding.

Here are a few highlights:
» Nanotech Gaming will host an independent shareholders meeting apart from NTEK's corporate shareholders meeting.
» The increased share structure was done for multiple reasons but it will attract new employees as well as finance acquisitions. No mention of the actual acquisitions in play but I do know there are a few and they are significant. I'm sure more details will be shared on this front shortly.
» NTEK is currently looking to hire a CFO (Chief Financial Officer). The current CFO has other responsibilities. This is a great move as being on high finance myself in the past I know how impactful a good CFO can be to a growth company.
» A 4K music channel will launch next month.
» UltraFlix is growing exponentially and will be arriving on Apple products shortly. It was mentioned that several 1,000 NEW subscribers have joined just in the last few days!
» UltraFlix will have Warner Brothers, Lionsgate, Sony and other major studio's content shortly.
» NTEK is currently processing the entire Millennium Films catalog. This is beyond huge folks! Check out this link to see current content available. Homepage Link: goo.gl/DNYqJr
Perhaps the biggest news shared was that NTEK has bought 3 months of EXCLUSIVE rights to an Oscar award winning title and the name of this film will be released next week! This is game changing news as it's clear this will be a yet to be released feature and anyone who wants to see this in 4K MUST go to UltraFlix to view the first 3 months!
» UltraFlix will offer a subscription based model in the near future but new and popular titles will be on the VOD model.
This conference call is just a sneak peek into several of NTEK's business developments but there is a lot more that isn't currently being shared. This conference call might have felt underwhelming from a delivery standpoint but this type of transparency is extremely rare with OTC Market stocks.
It's become very apparent to the public that NTEK is now extremely focused on the longevity success of UltraFlix. Do NOT take their silence and lack of communication as a weakness right now because NTEK has come to the conclusion of letting their business developments speak for themselves.
We are expecting major PR's to drop over the next few weeks in regards to the business developments that they spoke about today but also other PR's that are currently being processed and negotiated.
We will be posting a separate post talking about the Millennium deal in the morning as this is way bigger than most think.
There was also no mention of any financial projections for 2015 during the call. I have a feeling we hear something on this front as early as next week. I've been told the growth in both revenue and profit for 2015 will be staggering.
Thanks for being a part of the BIG family!


https://www.facebook.com/BIGInvestmentGroupLL...48081093:0

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading